[Gothenburg, Sweden] – 28 October 2024 – Takara Bio Europe is pleased to announce the expansion of its Gothenburg facility with the addition of a custom manufacturing lab, which came into operation on October 1st. This new facility will serve the molecular biology needs of academic researchers, diagnostic labs, and biotech companies across Europe, the Middle East, and Africa (EMEA), producing up to 600,000 reactions per week. 

Previously focused on a wide range of stem cell products and reagents under the Cellartis brand, Takara Bio’s Gothenburg site now offers a comprehensive array of customised molecular biology products, including PCR and qPCR enzymes. With these expanded capabilities, customers can expect faster deliveries, personalised service, and real-time access to technical expertise, ensuring projects move forward efficiently while supporting sustainability goals through reduced carbon emissions.

"This expansion strengthens our ability to deliver custom solutions with increased flexibility and faster turnaround times," said Kristina Runeberg, Site Head, Takara Bio Europe – Swedish Filial. "By producing closer to our customers, we can better meet their needs while reducing our carbon footprint."

For more information about Takara Bio’s custom manufacturing services, visit www.takarabio.com.

About Takara Bio
Takara Bio Europe is a leading manufacturer and supplier of molecular and cellular research reagents and services. With over 25 years of experience, our high-quality, innovative tools help to accelerate translational and clinical discoveries.

Key products include SMART cDNA synthesis kits for a variety of samples and applications, including NGS, high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes), Cellartis stem cells and stem cell reagents, RT enzymes and SMART library construction kits, the innovative In-Fusion® cloning system, Guide-it gene editing tools, Tet-based inducible gene expression systems, and Living Colors® fluorescent proteins.

Takara Bio’s portfolio supports applications including NGS, gene discovery, regulation, and function studies, as well as genetic analysis, protein expression and purification, gene editing, stem cell studies, and plant and food research. For more information, visit www.takarabio.com.

Takara Bio Inc., a world leader in biotechnology research and development, offers a host of life science research solutions, from enzymes and GMP-grade reagents to contracted cell and gene therapy manufacturing services and is the developer of the RetroNectin® reagent, a world standard in gene therapy protocols. Takara Bio is committed to preventing disease and improving the quality of life for all people through the use of biotechnology.

Contact Information:
Claire Leyden
Content Marketing Specialist
Takara Bio Europe
claire_leyden@takarabio.com